HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
90.74
-2.04 (-2.20%)
Oct 10, 2025, 3:53 PM EDT - Market open
HealthEquity Revenue
HealthEquity had revenue of $325.84M in the quarter ending July 31, 2025, with 8.64% growth. This brings the company's revenue in the last twelve months to $1.27B, up 15.45% year-over-year. In the fiscal year ending January 31, 2025, HealthEquity had annual revenue of $1.20B with 20.03% growth.
Revenue (ttm)
$1.27B
Revenue Growth
+15.45%
P/S Ratio
6.34
Revenue / Employee
$406,708
Employees
3,120
Market Cap
7.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 1.20B | 200.19M | 20.03% |
Jan 31, 2024 | 999.59M | 137.84M | 16.00% |
Jan 31, 2023 | 861.75M | 105.19M | 13.90% |
Jan 31, 2022 | 756.56M | 22.99M | 3.13% |
Jan 31, 2021 | 733.57M | 201.58M | 37.89% |
Jan 31, 2020 | 531.99M | 244.75M | 85.21% |
Jan 31, 2019 | 287.24M | 57.72M | 25.15% |
Jan 31, 2018 | 229.53M | 51.16M | 28.68% |
Jan 31, 2017 | 178.37M | 51.58M | 40.69% |
Jan 31, 2016 | 126.79M | 38.93M | 44.31% |
Jan 31, 2015 | 87.86M | 25.84M | 41.67% |
Jan 31, 2014 | 62.02M | 15.93M | 34.56% |
Jan 31, 2013 | 46.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
HQY News
- 15 days ago - HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation - GlobeNewsWire
- 5 weeks ago - HealthEquity: Swing Trading Stock With A Beat And Raise - Seeking Alpha
- 5 weeks ago - HealthEquity, Inc. (HQY) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - HealthEquity Stock Climbs After Q2 Earnings Report: Here's Why - Benzinga
- 5 weeks ago - HealthEquity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 5 weeks ago - HealthEquity: Scale Platform With Asset‑Linked Revenues And Thick Incremental Margins - Seeking Alpha
- 6 weeks ago - HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education - GlobeNewsWire
- 2 months ago - CORRECTION - HealthEquity Community Foundation Expands National Impact with $50,000 in Grants - GlobeNewsWire